Cargando…
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
How chemotherapy affects carcinoma genomes is largely unknown. Here we report whole-exome and deep sequencing of 30 paired oesophageal adenocarcinomas sampled before and after neo-adjuvant chemotherapy. Most, but not all, good responders pass through genetic bottlenecks, a feature associated with hi...
Autores principales: | Findlay, John M., Castro-Giner, Francesc, Makino, Seiko, Rayner, Emily, Kartsonaki, Christiana, Cross, William, Kovac, Michal, Ulahannan, Danny, Palles, Claire, Gillies, Richard S., MacGregor, Thomas P., Church, David, Maynard, Nicholas D., Buffa, Francesca, Cazier, Jean-Baptiste, Graham, Trevor A., Wang, Lai-Mun, Sharma, Ricky A., Middleton, Mark, Tomlinson, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822033/ https://www.ncbi.nlm.nih.gov/pubmed/27045317 http://dx.doi.org/10.1038/ncomms11111 |
Ejemplares similares
-
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
por: MacGregor, T. P., et al.
Publicado: (2018) -
Technical and implementation issues in using next-generation sequencing of cancers in clinical practice
por: Ulahannan, D, et al.
Publicado: (2013) -
The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas
por: Dermanis, Alexander A., et al.
Publicado: (2023) -
Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007) -
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
por: Temko, Daniel, et al.
Publicado: (2018)